Premium
BioHarvest Sciences Inc (BHST)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-03-13 | Mr. David K. RyanVP of Investor Relations & Secretary | 8,77k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 4,15 | 20,20k | 76,72% |
| 2026-03-13 | Mr. Sharon MalkaIndependent Director | 8,17k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 19,60k | 71,48% |
| 2026-03-13 | Ms. Vivien RakibDirector | 8,17k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 19,60k | 71,48% |
| 2026-03-13 | Dr. Ilana BelzerCOO | 23,05k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 55,91k | 70,15% |
| 2026-03-13 | Dr. Yoheved HagayCo-Founder & CTO | 24,61k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 560,62k | 4,59% |
| 2026-03-13 | Dr. Malkit AzachiVP of Research & Development | 12,67k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 59,81k | 26,87% |
| 2026-03-13 | Mr. Ilan SobelDirector | 84,16k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 601,25k | 16,28% |
| 2026-03-13 | Dr. Zaki RakibCo-Founder, CEO, Executive Chairman & President | 85,79k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 209,89k | 69,12% |
| 2026-03-13 | Mr. John FiddickIndependent Director | 8,17k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 19,60k | 71,48% |
| 2026-03-13 | Jared Albert TurnerInitié | 35,05k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 63,62k | 122,67% |
| 2026-03-13 | Michal SapirInitié | 12,61k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 32,61k | 63,05% |
| 2026-03-13 | Ms. Anne BinderIndependent Director | 8,17k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 3,02 | 19,60k | 71,48% |
| 2026-03-13 | Bar MorehInitié | 21,73k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 41,73k | 108,67% |
| 2026-03-13 | Levy YehesketInitié | 11,43k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 11,43k | - |
| 2021-05-20 | Ms. Vivien RakibDirector | -207,51k | 903,01k | Vente | 4,35 | 3,37M | -5,79% |
| 2025-09-19 | Ms. Anne BinderIndependent Director | 1,75k | 11,38k | Derivative Exercise and Retained Stock | 6,50 | 17,71k | 10,97% |
| 2024-12-28 | Ms. Anne BinderIndependent Director | -1,75k | 0,00 | Other Derivative Disposition | - | 1,75k | -50,00% |
| 2025-08-25 | Mr. Sharon MalkaIndependent Director | 11,43k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 11,43k | - |
| 2025-08-25 | Ms. Vivien RakibDirector | 7,14k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | 11,43k | 166,66% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
